Novel coronavirus attacks and destroys T cells, just like HIV

The immune system has many components that work together in protecting the body from foreign invaders. One of the most important types of immune cells is T lymphocytes or T cells, a type of white blood cell that acts as the core of adaptive immunity, the system that modifies the immune response to specific pathogens.

Notice: The authors of the research paper that this news story reported upon have retracted this article. After the publication of this article, it came to the author's attention that in order to support the conclusions of the study, the authors should have used primary T cells instead of T cell lines. Additionally, there are concerns that the flow cytometry methodology applied here was flawed. These points resulted in the conclusions being considered invalid. All authors agree with this retraction.

T-lymphocytes attack a colony of fungi. Image Credit: UGREEN 3S / Shutterstock
T-lymphocytes attack a colony of fungi. Image Credit: UGREEN 3S / Shutterstock

Now, a team from the United States and China revealed evidence that the coronavirus disease, caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2), attacks the immune system’s T lymphocytes. The worrying findings highlight the destructive power of the novel coronavirus, which can destroy the immune system, leaving the patient unable to fight off the infection.

The novel coronavirus

Coronaviruses have been causing problems in humans for a long time. Though many versions of the virus are known to trigger only mild symptoms such as common colds. However, three recent types of coronavirus have caused deadly diseases – the severe acute respiratory syndrome (SARS) in China in 2002, the Middle East respiratory syndrome (MERS) in Saudi Arabia in 2012, and the current global pandemic, the coronavirus disease (COVID-19), which first emerged in Wuhan City, Hubei Province, in China December 2019.

The impact of the previous coronavirus outbreaks in 2002 and 2012 has been mild compared with the mayhem unleashed by the SARS-CoV-2. Within only a few months, the novel coronavirus has prompted most countries to go into lockdown, dwindling economies, and overwhelming health care systems with the more than 2 million people infected.

Meanwhile, scientists across the globe are racing to understand the SARS-CoV-2-in the hope of finding a treatment or cure. Now, the researchers’ surprise discovery has shed light on the potency of the novel coronavirus is killing powerful immune cells, which are supposed to kill the virus instead.

Novel Coronavirus SARS-CoV-2 Colorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (purple), isolated from a patient sample. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID
Novel Coronavirus SARS-CoV-2 Colorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (purple), isolated from a patient sample. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID

Taken as hostage

The researchers from the Fudan University in Shanghai, China, and the New York Blood Centre, has studied the virus’s action on T-lymphocyte cell lines. T lymphocytes or T cells work by identifying and eliminating foreign invaders in the body.

To arrive at their findings, published in the journal of Cellular & Molecular Immunology, the team captured a cell infected by the virus, penetrated the membrane, and injected toxic chemicals into the cell. After this, the chemicals killed both the virus and infected cells by tearing them into pieces.

Surprisingly, the team has found that when the coronavirus and the T cell came into contact with each other, the T cell became prey to the coronavirus, wherein a structure in the spike of the coronavirus triggered the attachment of a viral envelope and the cell membrane. After, the genes of the virus entered the T cell and overwhelmed it, took it hostage, and deactivated its ability to protect the body.

The team then tried to do the same with the SARS virus, and another coronavirus, but these pathogens were not able to infect T cells. The researchers suspect that the SARS virus, which caused an outbreak in 2002 to 2003, has a lack of a membrane fusion function. The virus can only infect cells that have a particular receptor protein called the angiotensin-converting enzyme 2 (ACE2). T cells contain only a few ACE2 receptor proteins.

SARS-CoV-2 viruses binding to ACE-2 receptors on a human cell, the initial stage of COVID-19 infection, conceptual 3D illustration credit: Kateryna Kon / Shutterstock
SARS-CoV-2 viruses binding to ACE-2 receptors on a human cell, the initial stage of COVID-19 infection, conceptual 3D illustration credit: Kateryna Kon / Shutterstock

It is an important discovery, knowing the effect of the SARS-CoV-2 on T cells, since this may show why the disease is spreading so quickly, and infecting so many across the globe. It also explains why certain vulnerable populations are at a high risk of dying from the infection, including those who are more than 65, those who are immunocompromised, and those with underlying medical conditions like lung disease, heart disease, diabetes, and hypertension.

Further investigation shows that patients who died from COVID-19 had damage to their bodies similar to both SARS and HIV. Also, the team found that unlike HIV that replicates faulty T cells, the coronavirus does not replicate, showing that the T cells and the virus may end up dying together.

Video of T Cells

Killer T Cell: The Cancer Assassin

Source:

COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). (2020). https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6

Journal references:

Correction notice: This article was on 14th April 2020 edited to correct the citation and link to the scientific paper.

Wang, X., Xu, W., Hu, G. et al. SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion. Cell Mol Immunol (2020). https://www.nature.com/articles/s41423-020-0424-9

Angela Betsaida B. Laguipo

Written by

Angela Betsaida B. Laguipo

Angela is a nurse by profession and a writer by heart. She graduated with honors (Cum Laude) for her Bachelor of Nursing degree at the University of Baguio, Philippines. She is currently completing her Master's Degree where she specialized in Maternal and Child Nursing and worked as a clinical instructor and educator in the School of Nursing at the University of Baguio.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Laguipo, Angela. (2020, July 05). Novel coronavirus attacks and destroys T cells, just like HIV. News-Medical. Retrieved on November 22, 2024 from https://www.news-medical.net/news/20200413/Novel-coronavirus-attacks-and-destroys-T-cells-just-like-HIV.aspx.

  • MLA

    Laguipo, Angela. "Novel coronavirus attacks and destroys T cells, just like HIV". News-Medical. 22 November 2024. <https://www.news-medical.net/news/20200413/Novel-coronavirus-attacks-and-destroys-T-cells-just-like-HIV.aspx>.

  • Chicago

    Laguipo, Angela. "Novel coronavirus attacks and destroys T cells, just like HIV". News-Medical. https://www.news-medical.net/news/20200413/Novel-coronavirus-attacks-and-destroys-T-cells-just-like-HIV.aspx. (accessed November 22, 2024).

  • Harvard

    Laguipo, Angela. 2020. Novel coronavirus attacks and destroys T cells, just like HIV. News-Medical, viewed 22 November 2024, https://www.news-medical.net/news/20200413/Novel-coronavirus-attacks-and-destroys-T-cells-just-like-HIV.aspx.

Comments

  1. Marcos Garcia-Ojeda Marcos Garcia-Ojeda United States says:

    I'm very confused by this paper and the linked citation.  The link citation titled "Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion" has nothing to do with T cells.  In this study the authors use a human kidney cell line, 293T, to study if they can inhibit cell fusion mediated by the SARS-CoV2 spike protein using a novel inhibitor EK1C4.  So either the author linked the wrong paper to her publication or she misunderstood the paper cited.

  2. Jonathan TURPIN Jonathan TURPIN Réunion says:

    1) Presence of spike protein in Tcells doesn't mean there are infected
    2) Figure 1g : 'T cells infection is abortive'
    3) No cytopathic or even cell count in this study how could you state that this virus is like HIV?

    • Terrence Miele Terrence Miele United States says:

      I'm not a doctor I'm a herbalist that does  a lot of research. I keep hearing about the spike proteins and how they're similar to HIV but no one's explaining it in our simple manner. If that was the case it seems like an awful short amount of time for natural selection to happen

  3. S Brooman S Brooman United Kingdom says:

    Many statements in this article absolutely not supported by the studies or present understanding of SARS-COV-2.  

    This is irresponsible writing.  If I didn't have a background in virology I might not have been able to fact check this - you are misleading people with radical and scary headlines and statements for exposure.  

    Be.  Better.

    • Tigran Haas Tigran Haas Sweden says:

      If this is misleading and scaring people and u have a background in virology please give us a more plausible explanation? I am all ears, i showed his article to 6 epidemilogist and they think there is something definately there...very logical...sars and mers were pretty easily mapped and counter measures found rather fast, this one is damn mystery in its complexity...

  4. Even Johannesen Even Johannesen Germany says:

    If the article ends like this: "Further investigation shows that patients who died from COVID-19 had damage to their bodies similar to both SARS and HIV. Also, the team found that unlike HIV that replicates faulty T cells, the coronavirus does not replicate, showing that the T cells and the virus may end up dying together." -there is no reason to open with a HIV-comparison.

  5. Tigran Haas Tigran Haas Sweden says:

    Brilliant! This confirms a number of other scientific articles and research that point to Covid 19 having elements of HiV AIDS virus therefore damage to immunity, complex behavior in the body and unknowables it leaves plus the difficult task of finding a vaccine or a cure...its a killer virus but a silent and easier one than AIDS...those of you tjat deny this better read up on published articles and some excellent research done in China and USA...time will show that this was the right reasoning...

  6. Wei Jiang Wei Jiang United States says:

    Look at their flow figure, the gating was not professional and the conclusion was wrong.

  7. Shannon Buckley Shannon Buckley United States says:

    This article has been retracted: https://www.nature.com/articles/s41423-020-0424-9

    "The authors have retracted this article. After the publication of this
    article, it came to the authors attention that in order to support
    the conclusions of the study, the authors should have used
    primary T cells instead of T cell lines. Additionally, there are
    concerns that the flow cytometry methodology applied here was
    flawed. These points resulted in the conclusions being considered
    invalid. All authors agree with this retraction."

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds nirmatrelvir-ritonavir reduces severe COVID-19 and long COVID risks in high-risk patients